Robert Brooks
Chief Executive Officer Radiance Biopharma
Robert Brooks serves as Chief Executive Officer of the Company. Robert brings over 30 years of biotechnology, financial and legal experience. He also serves as Founder, Chairman and Chief Executive Officer of Alphageneron Pharmaceuticals, a clinical stage company focused on natural killer (NK) cell and antibody-based therapies. In 2015, he founded and served as Chief Executive Officer of Aurora Biopharma, a biotechnology company with a mission to develop CAR T cell therapy for solid tumors. In 2012, he founded and served as Chief Executive Officer of Medvax Technologies, a clinical stage biotechnology company focused on developing dendritic cell cancer vaccines.
Seminars
Monday 23rd February 2026
Showcasing Development & Advantages of RB-601: A First-in-Class c-MET/EGFR Bispecific Nano ADC
12:00 pm
- Undergoing development of RB-601, a bispecific nano ADC
- Highlighting RRB-601 advantages against classical bispecific ADCs across tumour tissue penetration, improved anti-tumour activity and superior tolerability profile
- Exploring ongoing biomarker and clinical trial with potential across solid tumour indications
